Skip to content

Clinical-based prognosis prediction of upper gastrointestinal cancer

Clinical-based prognosis prediction of upper gastrointestinal cancer - Prognostic study of upper gastrointestinal cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200066670
Enrollment
Unknown
Registered
2022-12-13
Start date
2018-09-09
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

upper gastrointestinal cancer

Interventions

Observation group:NA

Sponsors

Peking University Cancer Hospital & Institute
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 120 Years

Inclusion criteria

Inclusion criteria: Patients aged 18 and above who were admitted to hospital from January 1, 2007 (including esophageal cancer, cardia cancer, gastric cancer, etc.)

Exclusion criteria

Exclusion criteria: No

Design outcomes

Primary

MeasureTime frame
Overall survival;

Secondary

MeasureTime frame
the number of lymph nodes harvested;number of lymph nodes positive for metastases;duration of surgery;intraoperative blood transfusion;postoperative complications;30-/90-day mortality;treatment cost;

Countries

China

Contacts

Public ContactZhonghu He

Peking University Cancer Hospital & Institute

zhonghuhe@foxmail.com15001231151

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026